AU2548095A - Human inhibitor of apoptosis gene 1 - Google Patents

Human inhibitor of apoptosis gene 1

Info

Publication number
AU2548095A
AU2548095A AU25480/95A AU2548095A AU2548095A AU 2548095 A AU2548095 A AU 2548095A AU 25480/95 A AU25480/95 A AU 25480/95A AU 2548095 A AU2548095 A AU 2548095A AU 2548095 A AU2548095 A AU 2548095A
Authority
AU
Australia
Prior art keywords
apoptosis gene
human inhibitor
inhibitor
human
apoptosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25480/95A
Inventor
Wei Wu He
Peter L Hudson
Craig A Rosen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU2548095A publication Critical patent/AU2548095A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
AU25480/95A 1995-05-11 1995-05-11 Human inhibitor of apoptosis gene 1 Abandoned AU2548095A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002220670A CA2220670A1 (en) 1995-05-11 1995-05-11 Human inhibitor of apoptosis gene 1
PCT/US1995/005922 WO1996035703A1 (en) 1995-05-11 1995-05-11 Human inhibitor of apoptosis gene 1

Publications (1)

Publication Number Publication Date
AU2548095A true AU2548095A (en) 1996-11-29

Family

ID=25679809

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25480/95A Abandoned AU2548095A (en) 1995-05-11 1995-05-11 Human inhibitor of apoptosis gene 1

Country Status (4)

Country Link
EP (1) EP0830375A4 (en)
AU (1) AU2548095A (en)
CA (1) CA2220670A1 (en)
WO (1) WO1996035703A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156535A (en) 1995-08-04 2000-12-05 University Of Ottawa Mammalian IAP gene family, primers, probes, and detection methods
AUPN727595A0 (en) * 1995-12-22 1996-01-18 Walter And Eliza Hall Institute Of Medical Research, The Therapeutic compositions
US6133437A (en) * 1997-02-13 2000-10-17 Apoptogen, Inc. Modulation of IAPs for the treatment of proliferative diseases
AU5065098A (en) * 1996-11-15 1998-06-10 University Of Ottawa Modulators of ovarial apoptosis related to iap
US6472172B1 (en) * 1998-07-31 2002-10-29 Schering Aktiengesellschaft DNA encoding a novel human inhibitor-of-apoptosis protein
CN1413257A (en) * 1998-10-30 2003-04-23 内布拉斯加大学林肯分校 Trans-species transfer of apoptotic genes and transgenic plants developed thereby
AU5544500A (en) 1999-06-15 2001-01-02 Astrazeneca Ab Livin; inhibitor-of-apoptosis protein-3 (iap-3)
NZ546807A (en) 2002-03-27 2007-03-30 Aegera Therapeutics Inc Antisense IAP nucleobase oligomers and uses thereof
US8012944B2 (en) 2003-10-30 2011-09-06 Pharmascience Inc. Method for treating cancer using IAP antisense oligomer and chemotherapeutic agent

Also Published As

Publication number Publication date
EP0830375A1 (en) 1998-03-25
EP0830375A4 (en) 2001-11-21
CA2220670A1 (en) 1996-11-14
WO1996035703A1 (en) 1996-11-14

Similar Documents

Publication Publication Date Title
AU6614696A (en) Inhibition of gene expression
IL118101A0 (en) Inhibitors of farnesyltransferase
AU6034296A (en) Tricyclic inhibitors of protein farnesyltransferase
PL327569A1 (en) Promedications of thrombosin inhibitors
AU697619B2 (en) Enzymatic treatment of cocoa
AU7419096A (en) Treatment of vegetables
AU6614596A (en) Inhibition of gene expression
GB9526560D0 (en) Use of 2-Amino-Heterocycles
AU6692996A (en) Inhibitors of apoptosis
GB9512290D0 (en) Uses of polyhexanide
AU5381696A (en) Synthesis of bis-indolylmaleimides
AU5656796A (en) Use of sesquiterpenes for inhibiting oxidative enzymes
AU2548095A (en) Human inhibitor of apoptosis gene 1
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU4877196A (en) Derivatives of 3-pyrrolidylidene-2-one-cephalosporines
AU6667196A (en) Determination of chromium
AU7521096A (en) Enzymatic synthesis of l-fucose and l-fucose analogs
AU1181897A (en) Medical use of proteases
AU5989396A (en) Origin of replication complex genes
AU4670696A (en) Diagnosis of toxicoinfectious clostridiosis
AU4446396A (en) Use of dihydroxyacetone
AU6171196A (en) Therapeutic uses of ta99
EP0841910A4 (en) INHIBITION OF CoA-INDEPENDENT TRANSACYLASE AND APOPTOSIS
ZA955689B (en) Human inhibitor of apoptosis gene 1
HUT76555A (en) Derivatives of trans apovincaminic-acid-esters